Diagnostic value of serum glutathione peroxidase 3 levels in patients with lung cancer

Lung Cancer Biomarkers: Present Status and Future Developments

(2013) Philip T. Cagle et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Proteomic biomarkers in lung cancer

(2013) M. D. Pastor et al.   Clinical & Translational Oncology

Molecular biomarkers for future screening of lung cancer

(2013) Thomas A. Hensing et al.   JOURNAL OF SURGICAL ONCOLOGY

Genetics and biomarkers in personalisation of lung cancer treatment

(2013) Rafael Rosell et al.   LANCET

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response

(2011) Baishen Chen et al.   CANCER LETTERS

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression

(2011) Deep Agnani et al.   Journal of Ovarian Research

Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma

(2010) Eva Falck et al.   Cancer Cell International

Glutathione Pathway Genetic Polymorphisms and Lung Cancer Survival After Platinum-Based Chemotherapy

(2010) A. M. Moyer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends

(2010) Danny R. Youlden et al.   Journal of Thoracic Oncology

Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: A Korean Lung Cancer Registry Study

(2008) Kwang-Ho In et al.   LUNG CANCER